ZACHARY ADAMS: Open Payments
NPI 1326785684 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $145 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Gilead Sciences, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Dexcom, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, VIVITROL, Veozah, Dexcom G6 Transmitter, M-M-R II, Jornay PM, TZIELD, ROTATEQ.
Industry payments across UT — which companies pay providers there.
